![Olof Ulf Stefan Björklund](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Olof Ulf Stefan Björklund
Directeur/Membre du Conseil chez ProNoxis AB
Postes actifs de Olof Ulf Stefan Björklund
Sociétés | Poste | Début | Fin |
---|---|---|---|
ProNoxis AB
![]() ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Directeur/Membre du Conseil | - | - |
Swedish Pharmaceutical Society | Corporate Officer/Principal | - | - |
Historique de carrière de Olof Ulf Stefan Björklund
Anciens postes connus de Olof Ulf Stefan Björklund
Sociétés | Poste | Début | Fin |
---|---|---|---|
ANNEXIN PHARMACEUTICALS AB | Directeur/Membre du Conseil | 01/01/2016 | - |
OxyPharma AB | President | - | - |
Pharmacia AB | Corporate Officer/Principal | - | - |
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Directeur Général | - | 20/10/2014 |
Directeur des opérations | - | - |
Formation de Olof Ulf Stefan Björklund
University of Uppsala | Graduate Degree |
Statistiques
Internationale
Suède | 8 |
Opérationnelle
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ANNEXIN PHARMACEUTICALS AB | Health Technology |
Entreprise privées | 5 |
---|---|
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Health Technology |
ProNoxis AB
![]() ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Health Technology |
OxyPharma AB | |
Swedish Pharmaceutical Society | |
Pharmacia AB | Health Technology |
- Bourse
- Insiders
- Olof Ulf Stefan Björklund
- Expérience